Laser therapy, more precisely called photobiomodulation, can reduce pain and improve function in some types of neuropathy, most reliably in painful diabetic peripheral neuropathy, when a trained clinician delivers it with the right wavelength and dose. It is not a universal fix, and results depend heavily on the device, the protocol, and how consistently you attend sessions. The sections below walk through what the trials actually found, how the biology works, and what to expect if you and your provider decide it is worth trying.
TL;DR:
- Laser therapy shows consistent pain reduction and nerve function improvement mainly in diabetic peripheral neuropathy, especially when specific wavelengths and protocols are used.
- The treatment’s effectiveness heavily depends on device type, accurate dosing, session count, and patient adherence, with most protocols involving 10 to 12 sessions over several weeks.
- Laser therapy works by boosting mitochondrial energy in damaged nerves and selectively reducing pain signals in small diameter fibers without impairing motor function.
- Evidence quality is still developing due to small sample sizes, protocol variability, and short follow-up periods, making standardization and long-term results uncertain.
- Laser therapy is best as part of a broader treatment plan, especially combined with blood sugar control in diabetic cases or rehab for traumatic nerves, and is not suitable for urgent or rapidly progressing symptoms.
The clinical picture on laser therapy nerve pain treatment is encouraging but not settled. Systematic reviews have found that low-level laser therapy can meaningfully reduce pain and improve select nerve function measures in diabetic peripheral neuropathy, though results shift depending on which wavelength and dosing parameters a given trial used. That heterogeneity is the central tension in this field. A protocol using a 632.8 nanometer cold laser and one using a Class IV deep tissue system are testing different tools, so pooling their results together tends to blur what actually works.
A few trials stand out for their specificity. One randomized comparison found laser therapy outperformed transcutaneous electrical nerve stimulation on both clinical pain scores and nerve conduction measures in people with diabetic peripheral neuropathy, with no adverse events reported in either arm. Another trial using multi-wavelength MLS laser technology reported significant reductions in VAS pain scores and improved Michigan Neuropathy Screening Instrument results in diabetic sensorimotor neuropathy.
Statistic callout: A randomized pilot trial testing 12 sessions of local photobiomodulation over 23 days found meaningful intragroup reductions in neuropathic pain scores and associated symptoms, though the small sample size kept researchers from declaring definitive superiority over the comparison group.
Three limitations recur across this body of evidence:
None of this means the evidence is weak, exactly. It means the evidence is real but still maturing, and a systematic review noted that precise dosing standardization remains the field’s biggest unresolved variable.
Laser pain relief starts at the mitochondrial level, not at the skin’s surface. Red and near-infrared light penetrates tissue and gets absorbed by cytochrome c oxidase, an enzyme inside mitochondria that drives ATP production. More available ATP gives stressed or damaged nerve cells more energy to repair membranes and restore normal signaling. The light also triggers nitric oxide release and shifts redox signaling in ways that improve local microcirculation and calm inflammatory cytokines around the nerve.
What makes this mechanism clinically interesting is selectivity. Electrophysiology studies show direct photobiomodulation on peripheral nerves attenuates activity in small diameter Aδ and C fibers, the fibers that carry pain signals, while leaving motor fiber function intact. That is a meaningfully different mechanism than a nerve block or an opioid, which dull pain broadly and often bring sedation or motor effects along with it. The tradeoff is that this precision only shows up when wavelength and dose land in the right window, which is why parameter selection matters as much as the fact of treatment itself.
Not all lasers used for cold laser neuropathy treatment are interchangeable, and the differences affect what a session can realistically achieve.
Trial protocols for nerve pain laser treatment commonly use wavelengths in the 600 to 1,100 nanometer range, since that window penetrates tissue effectively while still being absorbed by mitochondrial chromophores. Energy density (measured in joules per square centimeter) and power output (measured in milliwatts) determine the actual dose delivered per session, and most published protocols run somewhere between 10 and 12 sessions spread over several weeks to build a cumulative effect rather than a one-time result.
Pro Tip: Before starting treatment, ask your clinic exactly which device class they use, the specific wavelength, the total energy density delivered per session, and how the treating practitioner was trained on that device. A vague answer to any of those four questions is a signal to ask more questions before committing to a course of sessions.
A typical laser pain relief session is quiet and largely uneventful in the best way. The device sits against or just above the skin over the affected nerve pathway, and most patients feel nothing more than mild warmth, if that. There is no cutting, no needle, and no recovery downtime.
Side effects are minimal and clinical trials have generally reported no serious adverse events tied to properly delivered photobiomodulation. Still, a few situations call for caution: photosensitizing medications, active malignant lesions in the treatment area, and direct exposure over the eyes or a pregnant abdomen. Flag any of these to your clinician before the first session.
Before you commit to a course of treatment, ask:
The strongest evidence for laser therapy neuropathy treatment centers on painful diabetic peripheral neuropathy, where multiple RCTs show consistent pain and function improvements. Evidence for general peripheral somatosensory neuropathy is reasonably supportive, while results for traumatic nerve injury and carpal tunnel syndrome remain mixed and less conclusive.
For most patients, laser therapy works best as one piece of a broader plan rather than a stand-alone fix. Diabetic neuropathy responds better when laser sessions run alongside tight blood sugar control, and traumatic or compressive neuropathies often improve faster when combined with targeted rehab work like nerve flossing and structured exercise.
Some symptoms are not laser therapy candidates at all. New, rapidly progressive weakness, signs of infection, or sudden-onset numbness need urgent medical evaluation before anyone considers photobiomodulation as an option.
A sound approach to chronic nerve pain solutions starts with assessment, not equipment. Before recommending laser therapy, a clinician should evaluate the specific nerve involved, rule out red flags, and confirm the condition fits the profile where photobiomodulation has real supporting evidence, like painful diabetic peripheral neuropathy.
From there, laser sessions typically fit into a multimodal plan rather than standing alone:
The clinic structures its laser therapy service around an accessible, insurance-billed model, with outcomes tracked across the treatment course rather than judged after a single visit.
The evidence here deserves cautious optimism, not blanket enthusiasm. Photobiomodulation has real, replicated support for diabetic peripheral neuropathy pain, and the mechanism behind it (targeted small-fiber inhibition without motor disruption) is more biologically specific than most people assume. But protocols still vary too much between clinics and studies to promise a fixed number of sessions or a guaranteed outcome for every nerve condition. If you’re considering it, ask about the device and dosing, expect a multi-session course, and treat it as one part of a coordinated care plan, not a substitute for managing the underlying condition.
— Deane
Shephardhealth’s laser therapy is a direct, in-clinic alternative to relying solely on oral medication for nerve pain, treatment that targets the nerve pathway itself rather than just dulling the signal system-wide, with no prescription refills or sedation to manage around your day. Every plan starts with a proper assessment: your clinician reviews your nerve pain history, confirms laser therapy is a reasonable fit for your specific condition, and walks you through the device, wavelength, and expected session count before treatment ever begins.
Appointments are available, and the clinic bills most major insurance providers directly, so cost questions get answered before you commit to a course of care. Your first visit covers a full assessment and a clear treatment plan, the same structure used across Shephardhealth’s broader chiropractic and rehabilitation services. If nerve pain has been running your schedule instead of the other way around, book a visit and start with the laser therapy service page to see what a personalized plan looks like for your condition.
Nerve damage itself often cannot be fully reversed, but pain signaling and some nerve function can improve significantly with treatments like photobiomodulation, especially when combined with managing the underlying cause, such as blood sugar control in diabetic neuropathy.
There is no single best medication; commonly prescribed options include gabapentin, pregabalin, and certain antidepressants, but effectiveness varies by person and laser therapy is often used alongside, not instead of, these medications.
Many people report tingling, mild sensitivity changes, or a shift from sharp burning pain to a duller ache as nerve function improves, though sensations vary widely by condition and individual.
A combination approach tends to work best: medical management of the underlying condition, targeted therapies like laser treatment or physical rehab, and consistent tracking of what worsens or eases your specific symptoms.
No. Evidence is strongest for painful diabetic peripheral neuropathy, while results for traumatic nerve injuries and carpal tunnel syndrome are mixed, so candidacy depends on your specific diagnosis.
Same Day Appointments Available
We Direct Bill!